New medication for the treatment of benign prostatic hyperplasia.
Miller
C A
CA
D058891:5-alpha Reductase Inhibitors; D000736:Androstenes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001378:Azasteroids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D018120:Finasteride; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000188:drug therapy* / Q000451:nursing
D058891:5-alpha Reductase Inhibitors; D000736:Androstenes; D001378:Azasteroids; D018120:Finasteride